SCHEMBL8974185

SCHEMBL8974185

NS(=O)(=O)c1ccc(C2=CC(CO)C=C2c2ccc(F)cc2)cn1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA1 P00915 9/20 0.44
CA2 P00918 9/20 0.44
CA9 Q16790 9/20 0.44
CA12 O43570 7/20 0.44
CA4 P22748 4/20 0.39
CA5A P35218 3/20 0.39
CA6 P23280 2/20 0.39
CA7 P43166 2/20 0.39
CA13 Q8N1Q1 2/20 0.39
CA14 Q9ULX7 2/20 0.39
PTGS2 P35354 6/20 0.37
PTGS1 P23219 3/20 0.37
CA5B Q9Y2D0 1/20 0.35
HTR2A P28223 2/20 0.35
KCNH2 Q12809 2/20 0.35
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
TDO2 P48775 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8974667 0.88 CA1 (0.40) CA1CA2CA9CA12CA4
SCHEMBL8974563 0.87 PTGS2 (0.37) PTGS2PTGS1HTR2AKCNH2
SCHEMBL8974276 0.87 CA1 (0.39) CA1CA2CA9CA12CA4
SCHEMBL8974190 0.86 KIF11 (0.40) CA1CA2CA9CA12CA4
SCHEMBL8974178 0.83 CA1 (0.41) CA1CA2CA9CA12CA4
SCHEMBL8974506 0.82 CA1 (0.44) CA1CA2CA9CA12CA4
SCHEMBL8973747 0.81 PTGS2 (0.55) CA1CA2CA9CA12CA4
SCHEMBL8974346 0.81 CA1 (0.40) CA1CA2CA9CA12CA4
SCHEMBL8974235 0.80 PTGS2 (0.45) CA1CA2CA9CA12CA4
SCHEMBL8974086 0.80 CA1 (0.42) CA1CA2CA9CA12CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5576339-A Pyridyl substituted cyclopentadienes for the treatment of inflamation HUANG HORNG-CHIH (US) 1996-11-19 US disclosed
WO-1995030656-A1 SUBSTITUTED CYCLOPENTADIENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO disclosed
US-5418254-A Side effect reduction G. D. SEARLE & CO. (US) 1995-05-23 US disclosed